US 9,808,469 B2
Antitumor activity of multi-kinase inhibitors in triple negative breast cancer
Alberto Ocaña Fernández, Albacete (ES); Atanasio Pandiella Alonso, Salamanca (ES); and Francisco Morís Varas, Oviedo (ES)
Assigned to ENTRECHEM, S.L., Oviedo (ES)
Appl. No. 15/314,342
Filed by ENTRECHEM, S.L, Oviedo (ES)
PCT Filed May 27, 2015, PCT No. PCT/EP2015/061641
§ 371(c)(1), (2) Date Nov. 28, 2016,
PCT Pub. No. WO2015/181201, PCT Pub. Date Dec. 3, 2015.
Claims priority of application No. 14170596 (EP), filed on May 30, 2014.
Prior Publication US 2017/0196880 A1, Jul. 13, 2017
Int. Cl. A61K 31/553 (2006.01); A61K 31/555 (2006.01); A61K 31/337 (2006.01); A61K 31/502 (2006.01)
CPC A61K 31/553 (2013.01) [A61K 31/337 (2013.01); A61K 31/502 (2013.01); A61K 31/555 (2013.01)] 7 Claims
 
1. A composition comprising
a) a compound of Formula (III)

OG Complex Work Unit Drawing
and
b) at least one chemotherapeutic agent selected from carboplatin, docetaxel and olaparib.